US Stocks
/
Palvella Therapeutics, Inc. Share Price

Palvella Therapeutics, Inc. Share Price

NASDAQ: PVLA | Small Cap
$138.94
+$7.76 (5.92%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Palvella Therapeutics, Inc. Stock Performance

Open
$129.59
Prev. Close
$131.18
Circuit Range
N/A
Day Range
$129.59 - $139.69
Year Range
$66.51 - $160.48
Volume
11,891
Average Traded
$136.25

Palvella Therapeutics, Inc. Share Price Today

As of 10 October 2026, Palvella Therapeutics, Inc.'s share price is $138.94. The stock opened at $129.59, compared to its previous close of $131.18. During today's trading session, Palvella Therapeutics, Inc.'s share price traded between $129.59 and $139.69, with an average price of $134.64. Over the past 52 weeks, the stock has recorded a high of $160.48 and a low of $66.51. In terms of performance, Palvella Therapeutics, Inc.'s share price has risen by 8.29% over the last six months and is up 73.69% on a year-on-year basis.

Palvella Therapeutics, Inc. Share Price Chart

$129.59$139.69
L
Show Current Price
H

Palvella Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.56B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.28
Revenue (TTM)
$0.00
Return On Equity (TTM)
-28.45%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-92.69%

Palvella Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$11.35-$12.71-$15.77-$21.87
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-11.98%-24.08%-38.68%

Palvella Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$17.43-$41.72
Net Profit MarginN/AN/A
Income ChangeN/A-139.36%

About Palvella Therapeutics, Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Palvella Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$134.99
$138.93
-0.96%
Sep 2026
$150.16
$140.28
-6.57%
Aug 2026
$137.99
$150.14
+7.82%
Jul 2026
$149.11
$139.25
-9.06%
Jun 2026
$115.47
$153.13
+29.64%
May 2026
$129.47
$118.12
-7.93%
Apr 2026
$129.50
$128.30
+2.64%
Mar 2026
$139.98
$125.00
-7.84%
Feb 2026
$78.81
$135.63
+76.90%
Jan 2026
$100.00
$76.67
-26.39%
Dec 2025
$96.25
$104.16
+0.84%
Nov 2025
$80.00
$103.29
+29.12%

PVLA Share Price FAQs

What is Palvella Therapeutics, Inc. share price today?

chevron-up
Palvella Therapeutics, Inc. share price today is $138.94 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Palvella Therapeutics, Inc. stock?

chevron-up
The 52 week high of Palvella Therapeutics, Inc. stock is $160.48, while the 52 week low is $66.51 as of 10 Oct '26.

What is PVLA's market capitalisation today?

chevron-up
PVLA market capitalisation is $1.56B as of October 10, 2026, at 9:11 am IST.

What is PVLA's net income for the last quarter?

chevron-up
PVLA's net income for the last quarter is -21.87B USD.

What is the 5 year returns of PVLA?

chevron-up
The 5 year returns of PVLA is -62.08% as on 10 Oct '26.

What is the high & low stock price of PVLA today?

chevron-up
PVLA stock price hit a high of $139.69 and low of $129.59 as of 10 Oct '26.

Can I buy PVLA shares in India?

chevron-up
Yes. You can buy PVLA in India by opening an international trading account.